Okay, let's tackle this question. The patient is a 25-year-old woman with febrile illness, chest pain, facial rash, and joint pain. The CBC shows mild anemia and thrombocytopenia. She's prescribed corticosteroids. The question is about what enzyme the corticosteroids inhibit via inducing an inhibitor.

First, I need to recall the core concept here. Corticosteroids are immunosuppressive and anti-inflammatory. They work through various mechanisms, including inhibiting phospholipase A2. That enzyme is involved in the production of arachidonic acid, which is a precursor for prostaglandins and leukotrienes. These are inflammatory mediators. So, corticosteroids might induce an inhibitor of phospholipase A2.

Now, the correct answer would be related to phospholipase A2 inhibition. Let me think about the options. The question is about which enzyme is inhibited by an inhibitor induced by corticosteroids. So the answer is probably phospholipase A2. But wait, I should check the other options. Let's say the options are like cyclooxygenase (COX), lipoxygenase, maybe others. Corticosteroids don't directly inhibit COX; that's NSAIDs. So those options would be incorrect. Another possibility is 5-lipoxygenase, but again, that's more for leukotriene synthesis, and specific inhibitors are like zileuton. So the correct answer here is phospholipase A2.

The clinical pearl here is that corticosteroids inhibit phospholipase A2 by inducing lipocortin, which is the inhibitor. This is a key point for exams, differentiating corticosteroids from NSAIDs. Students often confuse the mechanisms, so emphasizing that corticosteroids act upstream by inhibiting phospholipase A2, whereas NSAIDs block COX enzymes downstream.

**Core Concept**
Corticosteroids exert anti-inflammatory effects by inducing *lipocortin*, a protein that inhibits **phospholipase A2** (PLA2). This enzyme catalyzes the release of arachidonic acid from membrane phospholipids, a critical step in prostaglandin and leukotriene synthesis.

**Why the Correct Answer is Right**
Corticosteroids bind to glucocorticoid receptors, triggering transcription of *lipocortin* (annexin A1). Lipocortin inhibits PLA2, preventing arachidonic acid release and downstream production of inflammatory mediators like prostaglandins and leukotrienes. This mechanism distinguishes corticosteroids from NSAIDs, which inhibit cyclooxygenase (COX) enzymes *after* arachidonic acid is released.

**Why Each Wrong Option is Incorrect**
**Option A:** *Cyclooxygenase-1* (COX-1) is inhibited by NSAIDs, not corticosteroids. COX-1 inhibition causes gastric mucosal injury.
**Option B:** *5-Lipoxygenase* is targeted by leukotriene inhibitors (e.g., zileuton), not corticosteroids.
**Option C:** *Phospholipase C* is involved in IP3/DAG signaling, unrelated to cort

✓ Correct Answer: C. Phospholipase A2